Unitedhealth (UNH) EBITDA (2009 - 2026)

Unitedhealth (UNH) has 18 years of EBITDA data on file, last reported at $9.0 billion in Q1 2026.

• EBITDA for Q1 2026 came in at $9.0 billion, down 1.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.8 billion (down 43.73% YoY), and the FY2025 annual result was $20.0 billion, down 40.02% from the prior year.
• EBITDA grew to $9.0 billion in Q1 2026 per UNH's latest filing, from $380.0 million in the prior quarter.
• Over five years, EBITDA peaked at $9.1 billion in Q1 2025 and troughed at $380.0 million in Q4 2025.
• A 5-year average of $7.1 billion and a median of $7.8 billion in 2024 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2025: EBITDA soared 30.64% in 2022, then plunged 95.11% in 2025.
• A 5-year view of EBITDA shows it stood at $6.9 billion in 2022, then advanced by 11.58% to $7.7 billion in 2023, then climbed by 1.09% to $7.8 billion in 2024, then sank by 95.11% to $380.0 million in 2025, then jumped by 2265.79% to $9.0 billion in 2026.
• Business Quant data shows UNH's EBITDA at $9.0 billion in Q1 2026, $380.0 million in Q4 2025, and $4.3 billion in Q3 2025.